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Abstract
Objective: The current multicentre randomized controlled trial assessed the clinical
efficacy of a combined mHealth intervention for eating disorders (EDs) based on cog-
nitive behavioral therapy (CBT).
Method: A total of 106 ED patients from eight different public and private mental
health services in Spain were randomly assigned to two parallel groups. Patients of
the experimental group (N = 53) received standard face-to-face CBT plus a mobile
intervention through an application called “TCApp,” which provides self-monitoring
and an online chat with the therapist. The control group (N = 53) received standard
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face-to-face CBT only. Patients completed self-report questionnaires on ED symp-
tomatology, anxiety, depression, and quality of life, before and after treatment.
Results: Significant reductions in primary and secondary outcomes were observed
for participants of both groups, with no differences between groups. Results also
suggested that the frequency with which patients attended their referral mental
health institution after the intervention was lower for patients in the experimental
group than for those in the control group.
Discussion: The current study showed that CBT can help to reduce symptoms relat-
ing to ED, regardless of whether its delivery includes online components in addition
to traditional face-to-face treatment. Besides, the additional component offered by
the TCApp does not appear to be promising from a purely therapeutic perspective
but perhaps as a cost-effective tool, reducing thus the costs and time burden associ-
ated with weekly visits to health professionals.
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1 | INTRODUCTION
In current societies, eating disorders (EDs) are a major cause of physical
and psychosocial disability and poor quality of life (Keski-Rahkonen &
Mustelin, 2016; Klump, Bulik, Kaye, Treasure, & Tyson, 2009), and are
associated with high mortality rates (Arcelus, 2011; Smink, van Hoeken, &
Hoek, 2013). In Spain, EDs were the second cause of disability-adjusted
life-years (DALY) among women in 2010 after anxiety disorders. This
fact highlights the need to prioritize such disorders in the Spanish public
health system (Lara et al., 2015), as well as to evaluate direct and indirect
costs associated with the disease (Kordy, 2005).
In general, one of the forms of psychological therapy for patients
with EDs that is recommended most highly is cognitive behavioral ther-
apy (CBT) (National Institute for Health and Care Excellence, 2017).
One important behavioral component in CBT for ED is the self-
monitoring of nutritional intake, as well as the thoughts and feelings
that go with it (Fairburn, 2008). Despite the increasing adoption of CBT
principles and techniques, many patients fail to continue to apply the
skills learned in treatment in their daily lives (Juarascio, Parker,
Lagacey, & Godfrey, 2018). In specific, although adherence to self-
monitoring is associated with better treatment outcomes in EDs
(Darcy, Adler, Miner, & Lock, 2014), it is sometimes a challenging task
for this group of patients, with many of them, mostly during adoles-
cence, complaining about difficulties associated with the daily use of
paper-and-pen records (i.e., forget to bring paper notes to therapy, fear
of losing them, or do not want to carry them everywhere with them)
(Anastasiadou, Folkvord, Serrano-Troncoso, & Lupiañez-Villanueva,-
2019; Lock, 2005). Taking also into account that this group of patients
experiences difficulties associated with their specific condition, such as
a low motivation for change and for receiving treatment, it is crucial to
investigate alternative methods for delivering self-monitoring tech-
niques based on CBT principles to these patients, such as through
mobile interventions (Casasnovas et al., 2007; Kazdin & Blase, 2011). In
addition, empirically supported treatment for EDs is only available to a
limited number of patients, making it important to explore ways to
expand the availability and reach of evidence-based psychological treat-
ments for EDs (Cooper & Bailey-Straebler, 2015; Kass, Kolko, &
Wilfley, 2013; Kazdin & Blase, 2011; Kazdin, Fitzsimmons-Craft, &
Wilfley, 2017; Simon & Ludman, 2009).
mHealth interventions for EDs hold a great promise for reaching
those in need of psychological treatment (Holmes et al., 2018). Multi-
ple studies have shown that both patients and clinicians consider
mHealth techniques that support and facilitate ED symptoms moni-
toring as highly acceptable and feasible—either as a sole or additional
treatment tool for EDs (Anastasiadou, Folkvord, & Lupiañez-
Villanueva, 2018; Darcy et al., 2014; Juarascio, Manasse, Goldstein,
Forman, & Butryn, 2015; Lindgreen, Clausen, & Lomborg, 2018;
Lindgreen, Lomborg, & Clausen, 2018). Up until now, however, the
clinical utility of mHealth interventions for people with EDs is not fully
clear, and high-quality research is largely lacking (Juarascio, Manasse,
et al., 2015; Lui, Marcus, & Barry, 2017).
When accurately conducted, app-based treatments may lead to
an improved form of traditional CBT by facilitating monitoring of
symptoms, offering patients the opportunity to communicate and
share difficulties and improvements with their therapist wherever and
whenever, and improving access to psycho-education and skills mate-
rials (Fairburn & Patel, 2017; Fairburn & Rothwell, 2015; Juarascio,
Goldstein, Manasse, Forman, & Butryn, 2015; Luxton, McCann, Bush,
Mishkind, & Reger, 2011).
The mobile application that will be tested in this study, called
TCApp, has been specifically developed for people with EDs and is
based on the general principles of CBT. It represents a tool for con-
necting patients with therapists in the time in-between medical con-
sultations using online food records, monitoring of thoughts, actions,
2 ANASTASIADOU ET AL.
and emotions, and bidirectional messages via chat between patients
and their therapists. Due to the principle 24 hr a day availability to
chat with their therapist and possibility of continuous self-monitoring,
patients may feel more accompanied in their treatment process and
may experience more support and self-confidence in dealing with
treatment challenges. Equally, by use of the app, therapists can track
patients online and have the opportunity to visualize their patients'
progress using graphs and reports, as well as to contact them via chat
when the need arises. The TCApp has been developed as a result of
fruitful partnership between technology experts from a company
called HealthApp, patients with EDs and ED specialists from different
mental health institutions in the area around Barcelona (Spain). It is
considered to be a patient-centered tool which, through gamification
elements (i.e., badges, points, scoreboards, alerts) increases patients'
engagement and adherence with CBT treatment.
The current study aims to assess the clinical efficacy of a com-
bined intervention for EDs that includes a mobile intervention
through the TCApp plus standard face-to-face CBT, in comparison to
standard face-to-face CBT alone. Based on results from previous ran-
domized controlled trials (RCT) showing more positive effects of
mHealth interventions for patients with ED as compared to traditional
treatment (Bauer, Percevic, Okon, Meermann, & Kordy, 2003;
Hildebrandt et al., 2017), we hypothesized that patients with the
TCApp plus standard face-to-face CBT would show more improve-
ment on primary (ED pathology) and secondary outcomes (depression,
anxiety, quality of life, total number of visits) than patients receiving
standard face-to-face CBT alone.
2 | METHOD
2.1 | Design and participants
A multicentre RCT was carried out with two parallel groups
(an intensive intervention group with standard CBT and TCApp, and a
standard CBT control group) with a 1:1 allocation.
Participants were recruited between February and September
2018. The sample of patients with EDs was recruited from different
public and private mental health services in Spain (Parc Taulí Hospital,
Balearic Island Health Service-Son Espases University Hospital, Sant
Joan de Déu Hospital, Niño Jesús University Children's Hospital, San
Carlos Clinic Hospital, Quiron Dexeus University Hospital and ABB
Center). All patients were over 12 years of age, had been diagnosed
with an eating or feeding disorder according to DSM-V criteria, and
were receiving a standard CBT treatment, with the support of a multi-
disciplinary team of different ED units (psychiatry, psychology, nutri-
tion, and nursing).
2.2 | Procedure
The study was approved by the Ethical Committees of all participating
hospitals. In addition, approval was obtained from the Ethical
Committee of the University leading the study (Open University of
Catalonia, UOC). The study was registered in ClinicalTrials.gov
(Identifier NCT03197519), and its protocol was previously published
elsewhere (Anastasiadou, Folkvord, & Lupiañez-Villanueva, 2018).
Therefore, we will only describe the most important aspects of the
study's procedure here.
Informed consent was obtained from all potential candidates for
the study. Clinical interviews and assessment for eligibility were then
carried out using the KSADS-PL or SCID-I interviews (First, Spitzer,
Gibbon, & Williams, 2002; Kaufman et al., 1997). Patients who were
identified as eligible, as well as their families, completed the baseline
questionnaires (T0). Patients who did not return the documents within
2 weeks received a reminder call.
After completion of the baseline questionnaires (T0), patients
were randomized across experimental group and control group.
Patients were allocated their condition using a computer-generated
randomization list (allocation ratio 1:1; block size of 10; stratified per
hospital). Patients were notified regarding the outcome of the ran-
domization in their next visit to the ED unit. Participants and ED spe-
cialists were since that moment aware of the allocated group, while
data manager/analyst (DA) remained blinded.
Instructions on how to use the TCApp were given to patients
from the experimental group by the ED specialist responsible for
online monitoring. Then, each group of patients received the treat-
ment that corresponded to their condition for a period of 12 weeks.
At the end of the 12-week treatment, evaluation T1 was carried out.
Due to high dropout rate from T0 to T1, no T2 evaluation was carried
out (although it had been planned previously). For a detailed descrip-
tion of the study procedure, the definition of the study variables and
assessment tools, the reader is referred to Figure 1 and Table 1 of the
published protocol study (Anastasiadou, Lupiañez-Villanueva, Faulí,
Arcal Cunillera, & Serrano-Troncoso, 2018).
2.3 | Interventions
The experimental group received a standard face-to-face CBT (treat-
ment as usual, TAU) in addition to the mobile health intervention using
the TCApp, for a time span of 12 weeks. During these 12 weeks, the
patient should use the TCApp daily, completing the self-records and/or
contacting his/her therapist via chat, when considered necessary. The
therapist responsible for the online monitoring should connect to the
online platform and perform the following actions at least once a week:
follow the patient's daily self-records, generate personalized reports or
graphs and communicate with him/her via chat. After a 12-week
period, patients from the experimental group and their therapists will
stop using the TCApp (they will be discharged).
The control group received standard treatment based on
face-to-face CBT (TAU), offered by the ED units that participated in
the study, for a similar amount of time. It is worth mentioning that
the frequency and intensity of CBT treatment changed depending
on whether the patient fulfilled the criteria for undergoing outpa-
tient or day hospital treatment. If they so wished, participants in the
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control group were given access to the TCApp 6 months after the
start of the study.
A related point to consider is that all ED units that have been chosen
to take part in the trial employed CBT as a standard treatment for EDs
and that ED specialists from the seven ED units (five psychologists, one
psychiatrist, and one nursing staff) had previously received a CBT-specific
training during their specialization internship. In addition, ED specialists
responsible for the online monitoring (experimental group) were trained
on the basic principles of the application and the online platform.
2.4 | Measures
Clinical interviews (First et al., 2002; Kaufman et al., 1997) were used
to assess ED diagnosis and comorbidities among participants. An addi-
tional interview was employed to assess socio-demographic and
illness-related characteristics in the sample.
The primary outcome of the study concerned ED symptomatol-
ogy and was assessed with the Eating Disorder Examination Ques-
tionnaire (EDE-Q) (Peláez-Fernández, Javier Labrador, & Raich, 2012),
and the Short Evaluation of Eating Disorders (SEED) (Bauer, Winn,
Schmidt, & Kordy, 2005). Secondary outcomes were general psycho-
pathology and quality of life, measured using the Beck Depression
Inventory (BDI-II) (Wiebe & Penley, 2005), the State-Trait Anxiety
Inventory (STAI) (Spielberger, Gorsuch, & Lushene, 1982), the
EuroQoL-EQ-5L (EQ-5D-5L), and the child-friendly EQ-5D version
(EuroQol Group, 1990). The variable called “total number of regular
visits” was also used as secondary outcome. It was assessed at T0 and
T1 by way of telephone interviews with the clinician responsible for
the online monitoring of each patient, and included the number of
visits to ED specialists (i.e., individual therapy psychologist, group
therapy psychologist, psychiatrist, nursing staff, other medical staff of
various departments/specialities, nutritionist, or social worker). An
additional variable that reflected the total number of emergency visits
was also used as a secondary outcome. Finally, internal consistencies
for all measures at pretreatment were good (see Table 2 for
Cronbach's αs).
2.5 | Data analysis
Prior to the study, we estimated that a sample size of 200 participants
(100 patients per study arm) would be recommended, increasing this
number to 250 to allow for a 25% loss to follow-up, and assuming an
α of .05 and a power of 0.80 (β − 1).
We tested the hypothesis of a higher improvement in primary
and secondary outcomes from pre- to posttreatment in participants
with the TCApp plus standard face-to-face CBT compared to patients
receiving standard face-to-face CBT alone, using two-level hierarchi-
cal linear models (HLMs). HLMs are considered one the best statistical
techniques to examine longitudinal changes in nested data (such as in
the case of individual participant data hierarchically nested within
Assessed for eligibility (n = 140)
Excluded (n = 34)
♦ Not meeting inclusion criteria (n = 2)
♦ Declined to participate (lack of 
motivation, lack of time, etc.) (n = 25)
♦ Parents declined to sign informed 
consent (n = 4)
♦ Other reasons (n = 3)
♦ Not completed T1 assessment (n = 14)
♦ Discontinued intervention (app use ≤4 
weeks)
Allocated to experimental group (TAU + 
TCApp; n = 53)
♦ Received allocated intervention (app use 
≥1 time) (n = 48)
♦ Completed T0 assessment (n = 51)
♦ Not completed T1 assessment (n = 22)
Allocated to control group (TAU; n = 53)
♦ Received allocated intervention (n = 53)
♦ Completed T0 assessment (n = 52)
Allocation
Follow-up
Randomized (n = 106)
Enrollment
T0 assessment (n = 106)
F IGURE 1 Flow of participants through each stage of the study [Color figure can be viewed at wileyonlinelibrary.com]
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TABLE 1 Baseline characteristics of all study participants, and separately for each group
Characteristics Intervention (n = 53) Control (n = 53) Total (n = 106) p value
Demographics
Age (years), M (SD) 17.25 (3.54) 18.88 (7.77) 18.06 (6.04) .557
Sex, n (%)
Male 5 (9.4) 4 (7.7) 9 (8.6) .99
Female 48 (90.6) 48 (92.3) 96 (91.4)
Highest level of education, n (%)
Primary 10 (18.9) 10 (19.2) 20 (19.0) .806
Secondary 22 (41.5) 20 (38.5) 42 (40.0)
Baccalaureate 7 (13.2) 8 (15.4) 15 (14.3)
Vocational training 2 (3.8) 4 (7.7) 6 (5.7)
University 11 (20.8) 9 (17.3) 20 (19.0)
Employment status, n (%)
Full-time job 0 1 (1.9) 1 (1.0) .447
Part-time job 3 (5.7) 5 (9.6) 8 (7.6)
Student 48 (90.6) 45 (86.5) 93 (88.6)
Sick leave 2 (3.8) 0 2 (1.9)
Retired 0 1 (1.9) 1 (1.0)
Currently living together, n (%)
Nuclear family 38 (73.1) 32 (61.5) 70 (67.3) .411
Single parent family—mother 6 (11.5) 9 (17.3) 15 (14.4)
Single parent family—father 2 (3.8) 0 2 (1.9)
Single parent family—joint custody 2 (3.8) 3 (5.8) 5 (4.7)
Grandparent family 0 1 (1.9) 1 (1.0)
Proper family/partner 1 (1.9) 4 (7.7) 5 (4.7)
Living alone 3 (5.8) 3 (5.8) 6 (5.7)
Clinical data
Evaluation center, n (%)
PT 7 (13.2) 9 (17.0) 16 (15.1) .669
BAL 6 (11.3) 3 (5.7) 9 (8.5)
SJD 13 (24.5) 18 (34.0) 31 (29.2)
NJ 11 (20.8) 7 (13.2) 18 (17.0)
SC 4 (7.5) 5 (9.4) 9 (8.5)
DEX 1 (1.9) 0 1 (0.9)
ABB 11 (20.8) 11 (20.8) 22 (20.8)
Diagnosis, n (%)
AN-restrictive 26 (49.1) 25 (47.2) 51 (48.1) .299
AN-purging 3 (5.7) 4 (7.5) 7 (6.6)
BN 5 (9.4) 8 (15.1) 13 (12.3)
BED 4 (7.5) 0 4 (3.8)
OSFED 15 (28.3) 16 (30.2) 31 (29.2)
BMI, M (SD) 20.54 (4.45) 20.14 (3.59) 20.34 (4.03) .808
Comorbidity Axis I, n (%)
Yes 22 (41.5) 23 (44.2) 45 (42.9) .845
No 31 (58.5) 29 (55.8) 60 (57.1)
Duration ED (since onset; months), M (SD) 39.62 (40.29) 47.56 (62.03) 43.59 (52.20) .752
Duration all treatments, M (SD) 25.88 (35.16) 19.04 (20.39) 22.46 (28.81) .772
(Continues)
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treatment groups; Gallop & Tasca, 2009; Singer & Willett, 2003). Their
main advantage is the flexibility in handling missing data (Gallop &
Tasca, 2009), a common occurrence in longitudinal studies. We ran
intent-to-treat (ITT) analyses, examining the longitudinal changes of
all participants according to their assigned treatment group and
regardless of actual adherence to the treatment protocol.
We first tested if data were missing at random and if having any
missing data were significantly related to outcomes through a pattern
mixture model (Gallop & Tasca, 2009). Because all outcomes were
measured across two time-points (pre- and posttreatment), we were
only able to test a linear “time” slope (see Data S1 for the multilevel
model). Analyses were controlled for several individual-level
covariates, namely age, the number of times the App was used, dura-
tion in months of the eating disorder, diagnosis (dummy coded), the
presence of an Axis I diagnosis, and current pharmacotherapy. All
covariates were grand-mean centered.
Effect sizes indicating the proportion of within-person variance
accounted for by adding the linear parameter and were assessed and
reported using pseudo-R2 (Raudenbush & Bryk, 2002). Their magnitude
was interpreted according to guidelines (0.01 = small, 0.06 = medium,
>0.14 = large; Cohen, 1988). We additionally reported Cohen's d for
the between-groups differences at posttreatment on all the main and
secondary outcomes. Their magnitude was interpreted according to
guidelines (small ≥ 0.20; medium ≥ 0.50; large ≥ 0.80; Cohen, 1988).
Analyses were conducted using SPSS version 26.0 (IBM
Corp., 2013) and HLMs version 7.0.3 (Raudenbush, Bryk, Cheong, &
Congdon, 2011). All statistical tests were two-tailed and maintained a
5% significance threshold.
3 | RESULTS
3.1 | Preliminary analyses
We found few outliers at the two time points (T0 and T1) for frequen-
cies of primary and secondary outcomes, so extreme scores were
brought into range (Tabachnick & Fidell, 2007). According to their
skewness and kurtosis values, few variables (SEED BN severity index
and BMI) were also non-normally distributed. A square-root or log10
transformation corrected the violation of this assumption, however
analyses run with and without transformed variables led to similar
results. Thus, we reported results with untransformed values for ease
of interpretation (Tabachnick & Fidell, 2007). Because the variable
“total number of visits to emergency departments” was strongly asym-
metrical (i.e., less than 15% participants accessed emergency depart-
ments, and among those only 1–2 participants per group had two
visits during the 3 months before), this variable was dichotomized and
data were analyzed through hierarchical generalized linear models
(HGLMs; see Data S1 for the multilevel model).
Finally, we tested if the data was missing at random using a pat-
tern mixture model (Gallop & Tasca, 2009): the nonsignificant effects
of the missing data pattern (dropouts vs. completers) suggested that
all data were missing at random and that the estimates of effects were
unbiased by the presence of dropouts.
3.2 | Patient characteristics
Of the 250 patients approached for the current study a total of
140 were enrolled, 34 of which were excluded or refused to partici-
pate. Patients not interested in participating most often reported
lack of motivation or lack of time (n = 25). In some cases, parents
declined to sign the informed consent (n = 4). Thus, the final study
sample was of 106 patients, 53 of which were randomized to the
intervention and 53 to the control group. Figure 1 displays the
CONSORT diagram.
Regarding the frequency of the TCApp use by participants from
the experimental group, the mean app use was M = 7.11 (SD = 4.56;
range = 0–12). In specific, five users did not use the application at all,
12 users discontinued intervention (used the app for less than
4 weeks) and 35.8% of users used the app during 12 out of 12 weeks.
We compared the sociodemographic and clinical characteristics
of (1) patients in the intervention and in the control group and of
(2) dropouts and study completers through chi-square and Fisher
exact test (for frequencies), and Mann–Whitney U test (for continuous
variables). In both cases, no between-group differences were
observed for any of the baseline variables, besides a significantly
higher frequency of Axis I comorbidities among dropouts compared to
study completers (p = .040). Of note, once the intervention began
dropout rate was lower in the intervention group (30.2%) compared
TABLE 1 (Continued)
Characteristics Intervention (n = 53) Control (n = 53) Total (n = 106) p value
Current treatment type, n (%)
Day hospital 27 (50.9) 25 (48.1) 52 (49.5) .846
Outpatient 26 (49.1) 27 (51.9) 53 (50.5)
Pharmacological treatment, n (%)
Yes 35 (66) 28 (52.8) 63 (59.4) .235
No 18 (34) 25 (47.2) 43 (40.6)
Abbreviations: ABB, ABB Center; BAL, Balearic Island Health Service; NJ, Niño Jesús University Children's Hospital; PT, Parc Taulí Hospital; SC, San Carlos
Clinic Hospital; SJD, Sant Joan de Déu Hospital.
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TABLE 2 Means, SD, total N, effect sizes (Cohen's d between groups at T1) and Cronbach's αs (computed at pretreatment) for all
psychological variables across the two time points, and separately for the intervention and control groups
Variable N Mean (SD) N Mean (SD) Effect sizea α
T0 T1
EDE-Q total 91 2.70 (1.67) 70 1.93 (1.48) 0.11 .96
Intervention 47 2.83 (1.54) 39 2.01 (1.46)
Control 44 2.55 (1.78) 31 1.84 (1.53)
EDE-Q restriction 91 2.18 (1.80) 70 1.42 (1.43) −0.07 .89
Intervention 47 2.22 (1.67) 39 1.38 (1.36)
Control 44 2.14 (1.94) 31 1.48 (1.54)
EDE-Q eating concern 91 2.20 (1.52) 70 1.51 (1.35) 0.07 .82
Intervention 47 2.27 (1.43) 39 1.56 (1.37)
Control 44 2.13 (1.64) 31 1.46 (1.34)
EDE-Q shape concern 91 3.30 (1.96) 70 2.44 (1.79) 0.18 .95
Intervention 47 3.53 (1.84) 39 2.58 (1.77)
Control 44 3.05 (2.07) 31 2.27 (1.82)
EDE-Q weight concern 92 2.74 (1.79) 70 2.04 (1.63) 0.15 .83
Intervention 47 2.83 (1.72) 39 2.16 (1.62)
Control 45 2.64 (1.82) 31 1.91 (1.65)
SEED AN total severity index 89 0.83 (0.48) 69 0.68 (0.50) −0.09 –
Intervention 48 0.85 (0.47) 38 0.66 (0.48)
Control 41 0.81 (0.50) 31 0.70 (0.53)
SEED BN total severity index 92 0.54 (0.47) 69 0.40 (0.41) 0.09 –
Intervention 48 0.58 (0.50) 38 0.41 (0.39)
Control 41 0.49 (0.44) 31 0.38 (0.44)
BDI-II total 92 23.29 (14.10) 69 15.45 (13.04) 0.07 .91
Intervention 48 23.66 (13.50) 38 15.85 (13.62)
Control 44 22.89 (14.87) 31 14.95 (12.49)
STAI State 92 47.72 (13.80) 69 43.36 (12.84) 0.15 .95
Intervention 48 47.73 (14.36) 38 44.22 (13.65)
Control 44 47.70 (13.32) 31 42.32 (11.90)
EQ-5D-5L (adults) 20 0.86 (0.09) 22 0.88 (0.15) 0.88 –
Intervention 11 0.86 (0.08) 14 0.92 (0.10)
Control 9 0.86 (0.11) 8 0.80 (0.19)
Total visits 100 30.09 (30.38) 102 26.99 (27.87) −0.02 –
Intervention 52 33.54 (33.59) 52 26.77 (24.27)
Control 48 26.35 (26.30) 50 27.22 (31.42)
Emergency visits,b n (%) 106 15 (14.1) 106 10 (9.4) – –
Intervention 53 8 (15.1) 53 6 (11.3)
Control 53 7 (13.2) 53 4 (7.5)
BMI 106 20.34 (4.03) 106 20.53 (4.05) 0.11 –
Intervention 53 20.54 (4.45) 53 20.75 (4.39)
Control 53 20.14 (3.59) 53 20.31 (3.70)
Abbreviations: α, Cronbach's α at pretreatment; AN, anorexia nervosa; BDI-II, Beck Depression Inventory II; BMI, body mass index; BN, bulimia nervosa;
EDE-Q, Eating Disorder Examination Questionnaire; EQ-5D-5L, 5 level EQ-5D version; SEED, Short Evaluation of Eating Disorders Questionnaire; STAI
State, State-Trait Anxiety Inventory.
aCohen's d (between groups, at T1).
bDue to the extremely low occurrence, participants with more than one emergency visit during the past 3 months were considered as cases, and only one
frequency was counted.
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TABLE 3 Results from the hierarchical linear models indicating the growth parameter (β10) for each variable, and the effects of the
interaction between study condition (i.e., intervention and control groups) and the growth parameter (β11) for each variable
Variable β SE 95% CIs t values df p Pseudo R2
EDE-Q total
Time parameter β10 −0.84 0.16 −1.15, −0.53 −5.40 83 <.001 .38
Time × condition parameter β11 −0.73 0.46 −1.63, 0.17 −1.56 83 .122
EDE-Q restriction
Time parameter β10 −0.82 0.18 −1.17, −0.47 −4.51 83 <.001 .34
Time × condition parameter β11 −1.06 0.54 −2.12, −0.002 −1.96 83 .054
EDE-Q eating concern
Time parameter β10 −0.72 0.15 −1.01, −0.43 −4.83 83 <.001 .35
Time × condition parameter β11 −0.33 0.45 −1.21, 0.55 −0.74 83 .463
EDE-Q shape concern
Time parameter β10 −0.99 0.17 −1.32, −0.66 −5.79 83 <.001 .40
Time × condition parameter β11 −0.82 0.52 −1.84, 0.20 −1.59 83 .115
EDE-Q weight concern
Time parameter β10 −0.72 0.18 −1.07, −0.37 −4.09 83 <.001 .28
Time × condition parameter β11 −0.62 0.53 −1.66, 0.42 −1.19 83 .237
SEED AN total severity index
Time parameter β10 −0.18 0.05 −0.28, −0.08 −3.58 82 <.001 .25
Time × condition parameter β11 −0.28 0.15 −0.57, 0.01 1.88 82 .064
SEED BN total severity index
Time parameter β10 −0.13 0.05 −0.23, −0.03 −2.66 82 .009 .21
Time × condition parameter β11 −0.10 0.15 −0.39, 0.19 0.66 82 .510
BDI-II total
Time parameter β10 −8.86 1.61 −12.02, −5.70 −5.50 83 <.001 .41
Time × condition parameter β11 −3.34 4.76 −12.67, 5.99 −0.70 83 .485
STAI state
Time parameter β10 −5.28 1.66 −5.58, −4.98 −3.18 83 .002 .22
Time × condition parameter β11 −0.67 4.92 2.29, −3.63 −0.14 83 .891
EQ-5D-5L (adults)
Time parameter β10 0.01 0.08 −0.15, 0.17 0.08 16 .940 .62
Time × condition parameter β11 0.07 0.12 −0.17, 0.31 −0.58 16 .568
Total visits
Time parameter β10 −3.55 2.64 −8.72, 1.62 1.34 93 .184 .13
Time × condition parameter β11 −18.29 7.57 −33.13, −3.45 2.42 93 .017
Emergency visits
Time parameter β10 −0.90 0.55 −2.31, 0.51 −1.62 97 .110 –
Time × condition parameter β11 −1.43 1.47 −1.92, −0.94 −0.97 97 .333
BMI
Time parameter β10 0.20 0.10 0.004, 0.4 1.94 93 .056 .17
Time × condition parameter β11 0.11 0.30 −0.48, 0.70 −0.39 93 .700
Note: β10 indicates the person-level effect of the time parameter. β11 indicates the interaction between condition (i.e., intervention and control groups) and
the time parameter. Pseudo R2 refers to the amount of within-person variance accounted for by adding the time parameter to level 1 of the completely
unconditional multilevel model. R2 cannot be computed for dichotomous outcomes (i.e., frequency of emergency visits during the past 3 months).
Abbreviations: β, unstandardized regression weight; AN, anorexia nervosa; BDI-II, Beck Depression Questionnaire II; BMI, body mass index; BN, bulimia
nervosa; df, degrees of freedom (df are less than expected due to few missing values at level 2); EDE-Q, Eating Disorder Examination Questionnaire;
EQ-5D-5L, 5 level EQ-5D version; SEED, Evaluation of Eating Disorders Questionnaire; STAI State, State-Trait Anxiety Inventory.
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to the control group (43.4%). However, this difference was not statis-
tically significant (p = .227).
Sociodemographic and clinical characteristics for the total sample
and separately for the two study groups are provided in Table 1, while
means and standard deviations for psychological dimensions at the
two time points (pre and posttreatment) are reported in Table 2.
3.3 | Effect of the intervention on primary
outcomes
To test our first study hypothesis, we compared the effectiveness
of the two interventions designed to reduce patients' ED-related
symptoms using two-levels HLMs, controlling results for several
covariates.
Results showed that there was no significant difference between
the two groups on the longitudinal changes in the EDE-Q total and
subscale scores, and in the AN and BN total severity index of the
SEED (Table 3). Of note, the slope parameter β10 was always signifi-
cant, suggesting that CBT led to medium-to-large reductions in all
ED-related symptoms (R2 range: 0.21–0.40), regardless the group. At
posttreatment, the between-groups difference in all outcomes was
trivial (Cohen's d range: −0.09–0.18; see Table 2).
3.4 | Effect of the intervention on secondary
outcomes
To test our secondary hypotheses, we evaluated between-group
treatment effects on the secondary outcomes using HLMs, controlling
results for several covariates.
Results showed that there was no statistically significant difference
between the two groups on the longitudinal changes in the BDI-II,
STAIState, and EQ-5D-5L total scores, in the frequency of “total num-
ber of emergency visits” during the past 3 months as well as in the
BMI values. Interestingly, we found a significant effect of the Inter-
vention on the longitudinal changes in the variable “total number of
regular visits”, suggesting that the total number of visits of the experi-
mental group was significantly lower after treatment compared to the
control group (Table 3).
The slope parameter β10 of the variables BDI-II and STAI State
was significant, suggesting that CBT led to large reductions in depres-
sive and anxious symptoms (R2 range: 0.22–0.41), regardless the
group. At posttreatment, the between-groups difference in all out-
comes was trivial to large (Cohen's d range: −0.02, 0.88; see Table 2).
The effect size of 0.88 was attributable to EQ-5D-5L total score,
suggesting that patients in the intervention group reported a higher
Quality of Life at posttreatment than those in the control group.
All regression coefficients, SEs, t and p values for β10 (i.e., the
unstandardized regression coefficient for the average rate of growth
from pre- to posttreatment) and β11 (i.e., the interaction between
treatment condition and the time parameter) slope parameters are
reported in Table 3, while all Cohen's d are reported in Table 2.
4 | DISCUSSION
The current multicenter RCT assessed the clinical efficacy of a com-
bined intervention for EDs that included standard face-to-face CBT
plus the TCApp application when compared to standard face-to-face
CBT treatment. It was expected that patients in the experimental
group would show more positive effects of treatment compared to
those in the active control group. In contrast to our hypotheses,
results showed significant reductions in primary outcomes (eating dis-
order symptomatology) as well as secondary outcomes (anxiety,
depression, and quality of life) for participants in both groups, with
moderate effects and no differences between experimental and con-
trol group. Results also suggested that the frequency with which
patients attended their referral mental health institution after the
intervention was lower for patients in the experimental group than for
those in the control group. This finding might prove promising in the
light of reducing future direct and indirect costs associated with ED
treatment (Kordy, 2005).
These findings are in line with previous research which indicates
that mHealth interventions for patients with EDs focusing on self-
monitoring show limited additional effectiveness compared to active
control groups (Mazzeo et al., 2016). In a different study that used a
mobile application based on CBT principles for binge eating, however,
the effectiveness of the intervention in reducing ED symptoms was
indeed underscored (Hildebrandt et al., 2017). Similarly, Ruwaard
et al. (2013) found encouraging effects of online CBT for
BN. Comparing our findings with those in other studies should be
done with caution, however, given the differences between study
samples and implemented treatments. In addition, methodological
issues surrounding studies examining the efficacy and effectiveness of
mHealth interventions do not make it any easier to compare such
studies and draw firm conclusions (Lui et al., 2017).
It should also be noted that, while there were no significant dif-
ferences between the two treatment conditions with regard to ED
symptomatology and general wellbeing, we found significant differ-
ences, although with a small effect size, in the total number of times
patients attended their referral mental health institution to ask for
help from different health professionals. This included individual or
group therapy psychologists, psychiatrists, nursing staff, other medical
staff of various medical specialities, nutritionists, and social workers.
Findings suggest that the new component offered by the TCApp as
complementary to the face-to-face CBT intervention does not appear
to be promising from a purely therapeutic perspective but perhaps as
a cost-effective tool, an important outcome of the treatment condi-
tion that should also be taken into account and judged on its own
merit. An explanation of this finding may be that the group of patients
who were using the TCApp may have perceived increased autonomy
and self-confidence during their treatment process, which can be con-
sidered as an indicator of better adherence to their treatment (Crow
et al., 2013). In addition, integrating self-management through the app
in patients' daily life may be associated with reduced stigma and/or
shame associated with seeking in-person treatment and sharing ED-
related behaviors with the referral professional (Juarascio, Goldstein,
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et al., 2015; Juarascio, Manasse, et al., 2015) as well as with barriers
related to transportation and its costs and time barriers (Ali
et al., 2016; Juarascio, Goldstein, et al., 2015; Juarascio, Manasse,
et al., 2015). Another possibility is that the different outcome vari-
ables that we have used for clinical assessment were less sensitive to
detect adherence to the CBT treatment. Such an alternative explana-
tion might also take into account the short period of post-assessment
compared to a more direct and changing variable such as the patients'
total number of visits to a health professional.
Remarkably, overall adherence of the experimental group with
the TCApp presented some problems, taking into account that only
one third of the users (35.8%) of users used the app during the whole
duration of the intervention. At this point, it is worth mentioning
results from a previous qualitative study by Anastasiadou et al. (2019),
which examined TCApp's adoption levels by users. Results showed
that the app was deemed easy to use and acceptable by both patients
and clinicians as a complementary tool to regular treatment, although
concerns were expressed about the degree of personalization and the
overwhelming quantification of symptoms through the app, which
may have led some users to discontinue the online intervention.
The current study has several strengths and limitations. First, one
of its strengths is the inclusion of an active control group and a rigor-
ous assessment of our sample: through face-to-face diagnostic semi-
structured interviews, self-report questionnaires, as well as telephone
interviews. In addition, we recruited a heterogeneous sample with dif-
ferent ED diagnoses and illness durations, from a variety of private
and public health care institutions, and with the aim to reflect the situ-
ation of daily clinical practice in Spain as much as possible.
One of the limitations of the current study is the small sample
size, and the fact that some of our analyses are underpowered. For
example, the large effect sizes for EQ-5D-5L scores at posttreatment
suggest that the longitudinal between-group differences in this vari-
able could have been significant with a larger sample size. We should
mention here the difficulty we experienced in recruiting patients and
the high dropout rate, which makes generalizability of our results
decidedly more difficult. Taking into account the characteristics of our
sample (treatment-resistant disorders, as well as dealing with minors
under intensive treatment whose caregivers were not always willing
to collaborate due to the risks associated with the exposure of their
sons/daughters to app-based treatment), this is a common problem in
this area of research. As a result, the modest sample size and short
duration of post-assessment prevented us from determining if the
clinically meaningful effects of the TCApp may attain greater signifi-
cance over time—something that would have been facilitated with a
greater sample size. In addition, the small sample size did not allow us
to conduct specific analyses of subgroups of patients according to
their specific ED diagnosis, referral institution (public vs. private sec-
tor) or age (minors vs. adults). For future research, we also suggest
carrying out follow-up assessments at different time intervals, in order
to identify long-term predictors of good outcome or dropout.
In conclusion, based on our results and those of previous findings
(Anastasiadou, Folkvord, & Lupiañez-Villanueva, 2018; Fairburn &
Rothwell, 2015), CBT using either online monitoring through the
TCApp or paper-and-pen records may both be considered valuable
interventions for the treatment of patients with EDs. In addition,
patients' self-monitoring through the TCApp may be capable of
increasing patients' sense of autonomy, thus reducing the number of
weekly visits to a health institution. This comes on top of the fact that
it requires only a minimal online involvement for health professionals.
Nevertheless, a more detailed evaluation of treatment adherence
should be carried out (Loeb et al., 2005). In addition, the examination
of relevant clinical (ED diagnosis, symptom severity, psychiatric
comorbidity, treatment type or duration, referral health institution),
demographic (sex, age, economic status), and technical covariables
(a.o. smartphone literacy) at different follow-up periods and with a
larger sample should be taken into account. Finally, direct and indirect
costs relating to the use of the TCApp treatment should be examined
to provide evidence for its cost-effectiveness.
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